Authors
Worakij Chalermskulrat, Isabel P Neuringer, John L Schmitz, Diane J Catellier, Matthew J Gurka, Scott H Randell, Robert M Aris
Publication date
2003/6/1
Journal
Chest
Volume
123
Issue
6
Pages
1825-1831
Publisher
Elsevier
Description
Background
Obliterative bronchiolitis (OB) is the most important cause of long-term morbidity and mortality in lung transplant recipients, and probably results from alloimmune airway injury. Bronchiolitis obliterans syndrome (BOS), defined as a staged decline in pulmonary function, is the clinical correlate of OB.
Objective
Evaluation of the risk and severity of BOS on the basis of the incompatibility of donor and recipient human leukocyte antigen (HLA) molecules.
Design
Retrospective cohort study.
Setting
Large university hospital.
Participants
Lung transplant recipients between January 1990 and January 2000.
Measurements
We determined the BOS stage using internationally promulgated guidelines with a minor modification on all recipients at their 4-year transplant anniversary. Recipients whose graft function had deteriorated or who died due to causes other than BOS were excluded from the study. HLA loci mismatches …
Total citations
20042005200620072008200920102011201220132014201520162017201820192020202120222023202467965682176682314211